SlideShare una empresa de Scribd logo
1 de 7
Descargar para leer sin conexión
Technical Note                                              PhyNexus
                                                                                                      www.phynexus.com




Performance Enhancement and Automation
of Chromatin Immunoprecipitation (ChIP)
Procedures with PhyTip® Column Technology

Introduction
A central element of genome function is the expression of the individual genome elements and the factors that regulate those
events. Transcription factors, histone proteins, and covalent modifications of various proteins that interact with DNA are
critical players within the regulation of gene expression events. Due to their far-reaching functional implications, there are
currently many efforts to study these protein-DNA interactions and their associated covalent modifications in a detailed and
comprehensive manner 1,2. To study these events many investigators perform chromatin immunoprecipitation (ChIP) analyses
directed to specific genomic loci, whereby locus-specific primer sets are used for detection of the sequence of interest by
PCR3,4, which has recently been adapted to provide quantitative results by real-time PCR5,6. In addition, DNA microarray
technology is applied for genome-wide identification of those genomic loci that interact with specific interaction partners7or
interaction partners that possess specific covalent modifications 8. It is clear from the current breadth and scope of efforts
such as these that functional events governing gene regulation will continue to be the subject of intense study for many years
to come.
An essential component to successful ChIP analyses is the ability to conduct high-performance immunoaffinity separations of
crosslinked protein-DNA complexes, and key to that success is the quality of antibodies applied. For example, the antibodies
must possess high affinity to achieve maximum sensitivity for the targeted protein-DNA complex and thus minimize false
negatives, but must also possess very high specificity so as to minimize false positives due to background “noise” contributed by
non-specific binding events. The optimization process for ChIP antibodies must insure that rigorous wash procedures are
applied so that non-specific binding does not occur with the antibody or the antibody-support resin, yet at the same time this
washing must generate minimal losses of the target complex. With proper optimization, it has been shown in
genome-wide ChIP studies that false positive error rates can range from 4%7 to 27%9, with more typically quoted false positive
rates ranging between 6-10%10,11. False negative error rates – though obviously not directly measurable – are often quoted on
the basis of retrospective statistical analyses as being ~33%10. In addition, bioinformatics-based approaches have been
described for reducing the false positive error rate by identifying those regulatory sequence motifs most likely to be valid12.
These models have also been “boosted” with training data of validated positive and negative sequences13. While this boosting
was shown to provide 40% improvement over the non-boosted models, there were still invariably unaccounted-for false
positives.
Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP)
      Page 2                     Procedures with PhyTip® Column Technology



While thorough ChIP antibody optimization combined with rigorous bioinformatics can lead to reductions in false positives,
there will always be questions as to which positive interactions are true and which are false, thus requiring validation and
confirmation of reported protein-DNA interactions. This situation is eloquently summarized by authors9 that have
performed extensive work in the area of ChIP analyses:
    “…However, despite ever increasingly sophisticated statistical analysis of the genome-wide ChIP-chip data currently being
    performed in yeast10, independent and stringent empirical examination of…error rates will continue to be required to
    validate the global conclusions presented of genome-wide DNA-binding factor targets due to experimental error. These issues
    will become more pronounced as genome-wide analysis moves increasingly toward human studies where there are three
    orders of magnitude more DNA than in yeast.”

In view of the current state of ChIP analyses, one area that has not been rigorously optimized is the ChIP separation format.
An optimized separation format for ChIP analyses would insure that:
    • The antibody-protein-DNA complex is extracted to the Protein A or Protein G resin with maximum efficiency so
      that the highest possible target signal can be obtained. This insures the lowest possible rate of false negatives.
    • The trapped complex is washed in a manner that allows for efficient and complete removal of any non-specific
      binders. This should be achieved without excessive washing, transfer steps or the need for repeated ChIP rounds.
      This insures the lowest possible rate of false positives.
    • The trapped complex is eluted from the resin with extremely high yields and is eluted into a small volume that
      maximizes final target complex concentration. This insures maximum analytical rigor and sensitivity in determining
      enrichment factors.
    • Once the complex is eluted from the resin and is released from its crosslinking, the sample is in a form that lends
      itself to simple and quantitative DNA cleanup procedures. This further insures the lowest possible rate of false negatives.
All of the above steps are easily automated and each sample is subjected to a fresh separation column. This insures maximum
precision and zero carryover from sample-to-sample.
PhyNexus’ PhyTip column technology provides an optimized ChIP separation format that meets the specifications
described above. As shown in the photo below at left, the PhyNexus PhyTip 1000+ (top) and 200+ (bottom) column
products each possess a microcolumn of agarose-based resin at the opening of a pipet tip. As shown in the drawing below
at right, the design of the PhyTip column is such that highly efficient capture of the target protein is achieved by
maximizing transport to the agarose beads, which is enhanced through repeated back-and-forth sample exposure cycles.
This design also insures exceptional purity for the target protein by reducing the amount of unwashed volume to virtually
zero, thus minimizing any opportunities for non-specific binding events. Lastly, this same design provides for high-yield
elutions to occur into exceptionally small volumes. All of these features work together to provide dramatically increased
target protein concentrations at high levels of purity, all from starting samples as small as a few hundred microliters.




                                              PhyTip Column Technology

PhyTip column technology is a simple and straightforward means of performing fully optimized ChIP separations prior to
conventional ChIP, ChIP-chip or validation of individual ChIP-chip interactions – all of which can also be easily automated for
high-throughput procedures. The benefits described above as being provided by the PhyTip column technology are
illustrated below for different colon cancer cell lines and different histone modifications associated with the hMLH1 gene.
Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP)
       Page 3                   Procedures with PhyTip® Column Technology




Materials and Methods
Antibodies and cell lines
Histone H3 antibodies, SDS Lysis Buffer, ChIP Dilution Buffer, and salmon-sperm DNA/Protein A and Protein G agarose
were obtained from Upstate Biotechnology (Lake Placid, NY). RKO and SW480 cell lines were obtained from the American
Type Culture Collection. Dulbecco’s modified growth medium, L-15 medium and fetal bovine serum were obtained from
Invitrogen (Carlsbad, CA). Protein G PhyTip® Columns were from PhyNexus, Inc. (San Jose, CA).


Cell growth, crosslinking and chromatin preparation
RKO and SW480 colorectal cancer cell lines were obtained from American Type Culture Collection. RKO cells were
grown in high-glucose Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin. SW480 cells were grown in L-15 medium supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin in a humidified atmosphere containing 5% CO2 at 37°C.
EZChIP Assay Kit from Upstate Biotechnology was used for chromatin preparation with some modifications. 1x106 cells
were harvested from each cell line. Proteins were cross-linked to DNA by addition of formaldehyde directly to the culture
medium to a final concentration of 1% for 10 min at room temperature. The cross-linking reaction was quenched by adding
0.125 M glycine for 5 min at room temperature. The medium was then removed and cells were washed with 1X PBS
containing a combination of protease inhibitors. The PBS was removed and 0.2X trypsin was added to the cells. After a
5-min incubation at 37°C, ice-cold 1X PBS containing 10% FBS was added to stop trypsinization. The cells were pelleted, and
washed twice with 1X PBS plus protease inhibitors as above and resuspended in 200 µl 1% SDS, 10mM EDTA, 50mM Tris,
pH 8.1. The lysate from each cell line was diluted to a final volume of 2 mL in 0.01% SDS, 1.1% TritonX-100, 1.2mM EDTA,
16.7mM Tris-HCl, pH 8.1, 167mM NaCl.
DNA was sheared by sonication on ice using a Sonifier 250 ultrasonic cell disruptor (Branson Ultrasonics), 40% duty cycle
for 2 minutes at low power. Insoluble material was removed by centrifugation at 12,000 x g for 10 minutes at 4°. 20 µl of
each sample was retained as DNA input control for PCR analysis. The sonicated samples were pre-cleared with 80 µl of
salmon sperm DNA/Protein A and Protein G agarose beads (3:1 ratio of Protein A to Protein G) for 1 h at 4°C with
agitation followed by centrifugation at 4000 x g for 1 minute to pellet agarose beads.
The resulting supernatant from each cell line was divided equally into five 400 µl fractions. 2.5 µl of each antibody was
added to separate fractions and incubated overnight at 4ºC. Control samples containing no antibody were also prepared for
the two cell lines. Following the overnight incubation, each sample was divided into two 200 µl fractions for analysis using
conventional immunoprecipitation and PhyTip column enrichment.


Standard Chromatin Immunoprecipitation
Ten microliters of the 3:1 Protein A and Protein G agarose were added to each sample for one hour at 4ºC with agitation
followed by centrifugation at 4000 x g for 1 minute to pellet agarose beads. The beads were washed by resuspending in 1ml
ice-cold Low-Salt Wash Buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, 150mM NaCl) followed
by centrifugation at 4000 x g for 1 minute. The wash was repeated once with High Salt Wash Buffer (0.1% SDS, 1% Triton
X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, 500mM NaCl), once with LiCl Wash Buffer (0.25M LiCl, 1% IGEPAL-CA630,
1% deoxycholic acid (sodium salt), 1mM EDTA, 10mM Tris, pH 8.1) and two washes with TE Wash Buffer (10mM Tris-HCl,
1mM EDTA, pH 8.0). Following the final wash step, the immune complex was extracted from the beads by adding 120 µl
Elution Buffer (1% SDS. 0.1M NaHCO3) at room temperature for 15 minutes.
Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP)
      Page 4                    Procedures with PhyTip® Column Technology



Chromatin Immunoprecipitation with PhyTip Columns
Protein G PhyTip columns (5 µl bed volume) were blocked with 30 µg/mL salmon sperm DNA in PBS using a single
intake/expel cycle of 190 µl at a flow rate of 50 µl/min. The samples, wash, and elution buffers were placed in individual wells
of a microtiter plate (200 µl per well). Liquid handling steps were performed using the PhyNexus ME-200 computer-
controlled multichannel flow controller. All of the actions associated with the ChIP protocol can be completely automated
through an MEA Personal Purification System, as shown in Figure 1.




                                   Figure 1. PhyNexus MEA Personal Purification System


Capture of the immune complex was achieved by passing the samples back and forth through the column using an intake/
expel volume of 190 µl for nine cycles at a flow rate of 150 µl/min. The columns were washed with the same series of
buffers (Low Salt Wash, High Salt Wash, LiCl Wash, TE Wash) as described in the preceding section by passing 190 µl of
each wash solution through the columns for three cycles at a flow rate of 200 µl/min. The elution step was performed by
passing 120 µl of elution buffer back and forth through the column for five cycles at a flow rate of 50 µl/min. This process is
illustrated in Figure 2.




                                          Figure 2. PhyTip ChIP extraction process
Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP)
      Page 5                     Procedures with PhyTip® Column Technology



PCR Amplification
After elution from the beads and columns, each sample was heated at 65ºC for four hours to reverse the DNA-chromatin
crosslinking, followed by Proteinase K digestion, phenol:chloroform extraction and ethanol precipitation to recover the DNA.
Alternatively the DNA can undergo high-yield quantitative purifications in an entirely automated and high-throughput manner
by applying reverse-phase PhyTip columns. A 266 bp sequence of the 5’ upstream region of the hMLH1 gene (AB017806)
was amplified via PCR. The sequence of the primers used were: Forward: 5’ GGCTCCACCAC TAAATAACGCTG, Reverse:
5’ GCCTCTGCTGAGGTGATCTGG. Amplification was performed using Taq DNA Polymerase (Roche) using the following
program: 95ºC for 5 min (95ºC for 45 s, 60ºC for 45 s, 72ºC for 45 s for 35 cycles), 72ºC for 10 min, heated lid 105ºC. PCR
products were visualized using agarose gel electrophoresis and EtBr staining of amplicons.


Results
Acetylation and methylation patterns of histone H3 surrounding the promoter region of the mismatch repair gene hMLH1 in
colorectal cancer cell lines RKO (hMLH1 promoter silenced) and SW480 (hMLH1 promoter active) have been described
previously3, and were used for the purpose of comparing results obtained by standard ChIP procedures to those obtained by
PhyTip ChIP procedures.


Acetylation of Histone H3
The first histone modification studied was acetylation of Histone H3, with the gel image shown below in Figure 3.
The symbols above the individual lanes signify the absence (-) or presence (+) of antibody. Therefore, all lanes without
antibody should show no PCR product – any PCR product that does show in these lanes would be the result of inadequate
washing of non-specific DNA binding to the resin itself or any other potentially contaminating surfaces. In addition, for
those cases where antibody is present for this particular histone modification, there should be a clear PCR product present
in the case of SW480 cells and no PCR product in the case of RKO cells. Any PCR product that does show in the RKO cell
line-plus-antibody lane would be a false positive.
The PhyTip ChIP column procedure generates a strong PCR product for the SW480 cell line, with no discernible PCR
product in any of the other lanes – indicating that the wash procedure was sufficient for both cell lines, and that there was
not a false positive for the RKO cell line. The standard ChIP procedure generates a clearly discernible signal for the SW480
cell line, with no discernible signal in the “no antibody” lane for this same cell line. However, there are faint PCR products
in both lanes of the RKO cell line, indicating that the wash procedure for this cell line was not sufficient and runs the risk of
contributing to false positive signals, as shown in the “with antibody” lane for the RKO cell line.




                        Figure 3. Anti-acetyl-Histone H3 ChIP results, standard vs PhyTip processing
Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP)
       Page 6                     Procedures with PhyTip® Column Technology



Dimethylation of Histone H3-K9
The second histone modification studied was dimethylation of Histone H3-K9 with the gel image shown below in Figure 4.
Just as with the previous histone modification, all lanes without antibody should show no PCR product. Any PCR product
that does show in these lanes would be the result of inadequate washing of non-specific DNA binding to the resin itself or
any other potentially contaminating surfaces. In addition, for those cases where antibody is present for this particular
histone modification, there should be a clear PCR product present in the case of RKO cell lines and no PCR product in the
case of SW480 cell lines. Any PCR product that does show in the SW480 cell line-plus-antibody lane would be a false
positive.
The PhyTip ChIP column procedure generates a clearly discernible PCR product for the RKO cell line, with no discernible
PCR product in any of the other lanes, indicating that the wash procedure was sufficient for both cell lines, and that there
was not a false positive for the SW480 cell line. The standard ChIP procedure generates a very faint PCR product for the
RKO cell line (and is close to being undetectable, and hence a false negative), with no discernible signal in the “no antibody”
lane for this same cell line. However, there is also a faint PCR product in the “no antibody” lane for the SW480 cell line
(and contrary to what is already known about this histone modification, is actually more discernable than the “with
antibody” lane for the RKO cell line). This indicates that the wash procedure for this cell line was not sufficient and runs the
risk of contributing to false positives.




                           Figure 4. Anti-H3-K9-Me2 ChIP results, standard vs PhyTip processing


Discussion
As demonstrated for a known gene (hMLH1) oppositely regulated by two different H3 modifications in two different cell
lines, PhyTip column technology can provide significant improvements in signal-to-noise for ChIP analyses. This translates to
improvements in false positive error rates by providing more specific signals, as well as improvements in false negative error
rates by providing stronger signals.
These improvements in performance have implications in a variety of ChIP-related contexts. For one, conventional ChIP
analyses whereby a set or sets of loci-specific primers will benefit from having an overall higher degree of reliability and
automation. This would be specifically beneficial if a large number of experiments are performed for a particular event, or
for validation of individual genome-wide interactions reported – as suggested by previous authors. In addition, the
improvements can potentially lead to overall improvements in false negatives and false positives in ChIP-chip experiments.


                                                                                                                    continued...
Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP)
         Page 7                           Procedures with PhyTip® Column Technology



 Another advantage of the PhyTip column approach to ChIP analyses is that the improvements described above are obtained
 with significantly reduced starting sample quantities. In many standard ChIP procedures, the starting number of cells is
 typically 1x106, which are then lysed and commonly brought to a volume of 2 mL for standard ChIP processing. In the case
 of PhyTip processing for ChIP analyses, 0.2 mL of lysate volume representing the equivalent of 1x105 cells provided the
 improvements reported over processing this same volume by standard ChIP procedures. The improved results for smaller
 amounts of starting material mean that PhyTip ChIP approaches are well-suited to those situations where the starting cells
 are very precious and limited in quantity, such as primary tumor cell lines. In addition, this advantage also means that larger
 numbers of different experiments can be performed upon the same sample, e.g. examining a range of different histone
 modifications within a given sample.
 In addition to these substantial benefits for ChIP analyses, the PhyTip column approach to ChIP analyses lends itself to very
 simple automation of the separation process. This creates not only greater precision in ChIP analyses, but also dramatically
 reduces hands-on time. In addition, the PhyNexus MEA Personal Purification System has accessory items such as on-board
 heating that can automate the process of reversing protein-DNA crosslinking with 65°C incubations, and the ability to also
 perform standard pipetting operations on the MEA allows for addition of Proteinase K to these de-crosslinked samples.
 Furthermore, reverse-phase DNA purification can be performed in a high-yield and automated manner on the MEA Personal
 Purification System, thus eliminating the need for phenol-chloroform extractions requiring labor-intensive manipulation of
 the samples resulting in losses of DNA.


 Acknowledgments
 Drs. Jeffrey Sklar and Hui Li of Yale Medical School are gratefully acknowledged for providing the experimental work and
 data for this Technical Note.

 References
 1.    B.D. Strahl and C.D. Allis, “The language of covalent histone modifications”, Nature, 2000, 403, 41-45.
 2.    T. Jenuwein and C.D. Allis, “Translating the histone code”, Science, 2001, 293, 1074-1080.
 3.    J.A. Fahrner, S. Eguchi, J.G. Herman and S.B. Baylin, “Dependence of histone modifications and gene expression on DNA hypermethylation in cancer”,
       Cancer Res., 2002, 62, 7213-7218.
 4.    S. Chuikov, J.K. Kurash, J.R. Wilson, B. Xiao, N. Justin, G.S. Ivanov, K. McKinney, P. Tempst, C. Prives, S.J. Gamblin, N.A. Barlev and D. Reinberg,
       “Regulation of p53 activity through lysine methylation”, Nature, 2004, 432, 353-360.
 5.    J.C. Wang, M.K. Derynck, D.F. Nonaka, D.B. Khodabakhsh, C. Haqq and K.R. Yamamoto, “Chromatin
       immunopreciptation (ChIP) scanning identifies primary glucocorticoid receptor target genes”, Proc. Natl. Acad. Sci. USA, 2004, 101, 15603-15608.
 6.    J.V. Geisberg and K. Struhl, “Quantitative sequential chromatin                              immunoprecipitation,         a     method      for    analyzing
       cooccupancy of proteins at genomic regions in vivo”, Nucleic Acids Res., 2004, 32, e151.
 7.    T.H. Kim, L.O. Barrera, M. Zheng, C. Qu, M.A. Singer, T.A. Richmond,                                Y.     Wu,     R.D.       Green   and    B.   Ren,   “A
       high-resolution map of active promoters in the human genome”, Nature, 2005, 436, 876-880.
 8.    B.E. Bernstein, E.L. Humphrey, R.L. Erlich, R. Schneider, P. Bouman, J.S. Liu, T. Kouzarides and S.L. Schreiber, “Methylation of histone H3 Lys 4 in
       coding regions of active genes”, Proc. Natl. Acad. Sci USA, 2002, 99, 8695-8700.
 9.    M.J. Oberley, D.R. Inman and P.J. Farnham, “E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9”, J.
       Biol. Chem., 2003, 278, 42466-42476.
 10.   T.I. Lee, et al, “Transcriptional regulatory networks in Saccharomyces cerevisiae”, Science, 2002, 298, 799-804.
 11.   Z. Li, S. Van Calcar, C. Qu, W.K. Cavenee, M.Q. Zhang and B. Ren, “A global transcriptional regulatory role for c-Myc in Burkitt’s lymphoma cells”,
       Proc. Natl. Acad. Sci. USA, 2003, 100, 8164-8169.
 12.   E.M. Conlon, X.S. Liu, J.D. Lieb and J.S. Liu,                    “Integrating    regulatory    motif     discovery   and       genome-wide       expression
       analysis”, Proc. Natl. Acad. Sci. USA, 2003, 100, 3339-3344.
 13.   P. Hong, X.S. Liu, Q. Zhou, X. Lu, J.S. Liu and W.H. Wong, “A boosting approach for motif modeling using ChIP-chip data”, Bioinformatics, 2005, 21,
       2636-2643.



Copyright © 2005, PhyNexus, Inc., All Rights Reserved
PSL # 90-10-03 September 2005                                                                                                                www.phynexus.com

Más contenido relacionado

La actualidad más candente

Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Integrated DNA Technologies
 
Pyrosequencing slide presentation rev3.
Pyrosequencing slide presentation rev3.Pyrosequencing slide presentation rev3.
Pyrosequencing slide presentation rev3.
Robert Bruce
 
Bioinformatics workshop Sept 2014
Bioinformatics workshop Sept 2014Bioinformatics workshop Sept 2014
Bioinformatics workshop Sept 2014
LutzFr
 
Next generation sequencing
Next generation sequencingNext generation sequencing
Next generation sequencing
Dayananda Salam
 
The Next, Next Generation of Sequencing - From Semiconductor to Single Molecule
The Next, Next Generation of Sequencing - From Semiconductor to Single MoleculeThe Next, Next Generation of Sequencing - From Semiconductor to Single Molecule
The Next, Next Generation of Sequencing - From Semiconductor to Single Molecule
Justin Johnson
 

La actualidad más candente (20)

Advanced NGS Library Prep for Challenging Samples
Advanced NGS Library Prep for Challenging SamplesAdvanced NGS Library Prep for Challenging Samples
Advanced NGS Library Prep for Challenging Samples
 
Accurate DNA Methylation Analysis with Successful Bisulfite Conversion Webinar
Accurate DNA Methylation Analysis with Successful Bisulfite Conversion WebinarAccurate DNA Methylation Analysis with Successful Bisulfite Conversion Webinar
Accurate DNA Methylation Analysis with Successful Bisulfite Conversion Webinar
 
QIAseq Targeted DNA, RNA and Fusion Gene Panels
QIAseq Targeted DNA, RNA and Fusion Gene PanelsQIAseq Targeted DNA, RNA and Fusion Gene Panels
QIAseq Targeted DNA, RNA and Fusion Gene Panels
 
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
 
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for All
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for AllThe QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for All
The QIAseq NGS Portfolio for Cancer Research: Sample-to-Insight for All
 
Pyrosequencing slide presentation rev3.
Pyrosequencing slide presentation rev3.Pyrosequencing slide presentation rev3.
Pyrosequencing slide presentation rev3.
 
next generation sequencing (recent collection2018)
next generation sequencing (recent collection2018) next generation sequencing (recent collection2018)
next generation sequencing (recent collection2018)
 
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1
Digital RNAseq Technology Introduction: Digital RNAseq Webinar Part 1
 
Emergingroleo fmi rnainmedicalsciences
Emergingroleo fmi rnainmedicalsciencesEmergingroleo fmi rnainmedicalsciences
Emergingroleo fmi rnainmedicalsciences
 
DNA Sequencing from Single Cell
DNA Sequencing from Single CellDNA Sequencing from Single Cell
DNA Sequencing from Single Cell
 
IonGAP - an Integrated Genome Assembly Platform for Ion Torrent Data
IonGAP - an Integrated Genome Assembly Platform for Ion Torrent DataIonGAP - an Integrated Genome Assembly Platform for Ion Torrent Data
IonGAP - an Integrated Genome Assembly Platform for Ion Torrent Data
 
Ngs introduction
Ngs introductionNgs introduction
Ngs introduction
 
Bioinformatics workshop Sept 2014
Bioinformatics workshop Sept 2014Bioinformatics workshop Sept 2014
Bioinformatics workshop Sept 2014
 
RNASeq - Analysis Pipeline for Differential Expression
RNASeq - Analysis Pipeline for Differential ExpressionRNASeq - Analysis Pipeline for Differential Expression
RNASeq - Analysis Pipeline for Differential Expression
 
Next generation sequencing
Next generation sequencingNext generation sequencing
Next generation sequencing
 
Next-generation sequencing and quality control: An Introduction (2016)
Next-generation sequencing and quality control: An Introduction (2016)Next-generation sequencing and quality control: An Introduction (2016)
Next-generation sequencing and quality control: An Introduction (2016)
 
Introduction to Next-Generation Sequencing (NGS) Technology
Introduction to Next-Generation Sequencing (NGS) TechnologyIntroduction to Next-Generation Sequencing (NGS) Technology
Introduction to Next-Generation Sequencing (NGS) Technology
 
Single cell RNA sequencing; Methods and applications
Single cell RNA sequencing; Methods and applicationsSingle cell RNA sequencing; Methods and applications
Single cell RNA sequencing; Methods and applications
 
RNA Sequencing from Single Cell
RNA Sequencing from Single CellRNA Sequencing from Single Cell
RNA Sequencing from Single Cell
 
The Next, Next Generation of Sequencing - From Semiconductor to Single Molecule
The Next, Next Generation of Sequencing - From Semiconductor to Single MoleculeThe Next, Next Generation of Sequencing - From Semiconductor to Single Molecule
The Next, Next Generation of Sequencing - From Semiconductor to Single Molecule
 

Similar a Automation of Chromatin Immunoprecipitation

A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
Qing Chen
 
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Thermo Fisher Scientific
 
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Alberto Cuadrado
 
Nature BioTech RainDance.pdf
Nature BioTech RainDance.pdfNature BioTech RainDance.pdf
Nature BioTech RainDance.pdf
Michael Weiner
 

Similar a Automation of Chromatin Immunoprecipitation (20)

Poster
PosterPoster
Poster
 
MGG2003-cDNA-AFLP
MGG2003-cDNA-AFLPMGG2003-cDNA-AFLP
MGG2003-cDNA-AFLP
 
Cancer Research & the Challenges of FFPE Samples – An Introduction
Cancer Research & the Challenges of FFPE Samples – An IntroductionCancer Research & the Challenges of FFPE Samples – An Introduction
Cancer Research & the Challenges of FFPE Samples – An Introduction
 
Epigenetic
EpigeneticEpigenetic
Epigenetic
 
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
 
Gene overexpression protocol.doc
Gene overexpression protocol.docGene overexpression protocol.doc
Gene overexpression protocol.doc
 
JoB spike in manuscript 2014
JoB spike in manuscript 2014JoB spike in manuscript 2014
JoB spike in manuscript 2014
 
Highly Sensitive Droplet Digital PCR for the Detection of EGFR G719S and T790...
Highly Sensitive Droplet Digital PCR for the Detection of EGFR G719S and T790...Highly Sensitive Droplet Digital PCR for the Detection of EGFR G719S and T790...
Highly Sensitive Droplet Digital PCR for the Detection of EGFR G719S and T790...
 
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
 
Streamlined next generation sequencing assay development using a highly multi...
Streamlined next generation sequencing assay development using a highly multi...Streamlined next generation sequencing assay development using a highly multi...
Streamlined next generation sequencing assay development using a highly multi...
 
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
 
SMU Poster
SMU PosterSMU Poster
SMU Poster
 
Genome in a bottle for next gen dx v2 180821
Genome in a bottle for next gen dx v2 180821Genome in a bottle for next gen dx v2 180821
Genome in a bottle for next gen dx v2 180821
 
FFPE Applications Solutions brochure
FFPE Applications Solutions brochureFFPE Applications Solutions brochure
FFPE Applications Solutions brochure
 
2015 07 09__epigenetic_profiling_environmental_health_sciences_v42
2015 07 09__epigenetic_profiling_environmental_health_sciences_v422015 07 09__epigenetic_profiling_environmental_health_sciences_v42
2015 07 09__epigenetic_profiling_environmental_health_sciences_v42
 
2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented
 
Host cell protein dynamics in recombinant CHO cells-Impact from harvest to Pu...
Host cell protein dynamics in recombinant CHO cells-Impact from harvest to Pu...Host cell protein dynamics in recombinant CHO cells-Impact from harvest to Pu...
Host cell protein dynamics in recombinant CHO cells-Impact from harvest to Pu...
 
Nature BioTech RainDance.pdf
Nature BioTech RainDance.pdfNature BioTech RainDance.pdf
Nature BioTech RainDance.pdf
 
CHEM3204_PRAC_Manual_2016
CHEM3204_PRAC_Manual_2016CHEM3204_PRAC_Manual_2016
CHEM3204_PRAC_Manual_2016
 
Biopra activities
Biopra activitiesBiopra activities
Biopra activities
 

Más de Chris Suh

Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Automated Protein Purification Process Development on Caliper LifeSciences Sy...Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Chris Suh
 

Más de Chris Suh (10)

PhyScreen IMAC Resin Screening Kit for Process Development
PhyScreen IMAC Resin Screening Kit for Process DevelopmentPhyScreen IMAC Resin Screening Kit for Process Development
PhyScreen IMAC Resin Screening Kit for Process Development
 
Ion Exchange Resins in PhyTip Columns
Ion Exchange Resins in PhyTip ColumnsIon Exchange Resins in PhyTip Columns
Ion Exchange Resins in PhyTip Columns
 
BAC BV resins in PhyTip columns for Protein Purification
BAC BV resins in PhyTip columns for Protein PurificationBAC BV resins in PhyTip columns for Protein Purification
BAC BV resins in PhyTip columns for Protein Purification
 
High Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant LibraryHigh Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant Library
 
Antibody Glycan Analysis with Normal Phase PhyTip Columns
Antibody Glycan Analysis with Normal Phase PhyTip ColumnsAntibody Glycan Analysis with Normal Phase PhyTip Columns
Antibody Glycan Analysis with Normal Phase PhyTip Columns
 
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciencesProtein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
 
Automated Functional Antibody Purification
Automated Functional Antibody PurificationAutomated Functional Antibody Purification
Automated Functional Antibody Purification
 
Automated Protein Purificaton on Tecan Systems
Automated Protein Purificaton on Tecan SystemsAutomated Protein Purificaton on Tecan Systems
Automated Protein Purificaton on Tecan Systems
 
Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Automated Protein Purification Process Development on Caliper LifeSciences Sy...Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Automated Protein Purification Process Development on Caliper LifeSciences Sy...
 
PhyNexus Desalting Columns
PhyNexus Desalting ColumnsPhyNexus Desalting Columns
PhyNexus Desalting Columns
 

Último

Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
panagenda
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Victor Rentea
 

Último (20)

Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital Adaptability
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelMcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 

Automation of Chromatin Immunoprecipitation

  • 1. Technical Note PhyNexus www.phynexus.com Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP) Procedures with PhyTip® Column Technology Introduction A central element of genome function is the expression of the individual genome elements and the factors that regulate those events. Transcription factors, histone proteins, and covalent modifications of various proteins that interact with DNA are critical players within the regulation of gene expression events. Due to their far-reaching functional implications, there are currently many efforts to study these protein-DNA interactions and their associated covalent modifications in a detailed and comprehensive manner 1,2. To study these events many investigators perform chromatin immunoprecipitation (ChIP) analyses directed to specific genomic loci, whereby locus-specific primer sets are used for detection of the sequence of interest by PCR3,4, which has recently been adapted to provide quantitative results by real-time PCR5,6. In addition, DNA microarray technology is applied for genome-wide identification of those genomic loci that interact with specific interaction partners7or interaction partners that possess specific covalent modifications 8. It is clear from the current breadth and scope of efforts such as these that functional events governing gene regulation will continue to be the subject of intense study for many years to come. An essential component to successful ChIP analyses is the ability to conduct high-performance immunoaffinity separations of crosslinked protein-DNA complexes, and key to that success is the quality of antibodies applied. For example, the antibodies must possess high affinity to achieve maximum sensitivity for the targeted protein-DNA complex and thus minimize false negatives, but must also possess very high specificity so as to minimize false positives due to background “noise” contributed by non-specific binding events. The optimization process for ChIP antibodies must insure that rigorous wash procedures are applied so that non-specific binding does not occur with the antibody or the antibody-support resin, yet at the same time this washing must generate minimal losses of the target complex. With proper optimization, it has been shown in genome-wide ChIP studies that false positive error rates can range from 4%7 to 27%9, with more typically quoted false positive rates ranging between 6-10%10,11. False negative error rates – though obviously not directly measurable – are often quoted on the basis of retrospective statistical analyses as being ~33%10. In addition, bioinformatics-based approaches have been described for reducing the false positive error rate by identifying those regulatory sequence motifs most likely to be valid12. These models have also been “boosted” with training data of validated positive and negative sequences13. While this boosting was shown to provide 40% improvement over the non-boosted models, there were still invariably unaccounted-for false positives.
  • 2. Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP) Page 2 Procedures with PhyTip® Column Technology While thorough ChIP antibody optimization combined with rigorous bioinformatics can lead to reductions in false positives, there will always be questions as to which positive interactions are true and which are false, thus requiring validation and confirmation of reported protein-DNA interactions. This situation is eloquently summarized by authors9 that have performed extensive work in the area of ChIP analyses: “…However, despite ever increasingly sophisticated statistical analysis of the genome-wide ChIP-chip data currently being performed in yeast10, independent and stringent empirical examination of…error rates will continue to be required to validate the global conclusions presented of genome-wide DNA-binding factor targets due to experimental error. These issues will become more pronounced as genome-wide analysis moves increasingly toward human studies where there are three orders of magnitude more DNA than in yeast.” In view of the current state of ChIP analyses, one area that has not been rigorously optimized is the ChIP separation format. An optimized separation format for ChIP analyses would insure that: • The antibody-protein-DNA complex is extracted to the Protein A or Protein G resin with maximum efficiency so that the highest possible target signal can be obtained. This insures the lowest possible rate of false negatives. • The trapped complex is washed in a manner that allows for efficient and complete removal of any non-specific binders. This should be achieved without excessive washing, transfer steps or the need for repeated ChIP rounds. This insures the lowest possible rate of false positives. • The trapped complex is eluted from the resin with extremely high yields and is eluted into a small volume that maximizes final target complex concentration. This insures maximum analytical rigor and sensitivity in determining enrichment factors. • Once the complex is eluted from the resin and is released from its crosslinking, the sample is in a form that lends itself to simple and quantitative DNA cleanup procedures. This further insures the lowest possible rate of false negatives. All of the above steps are easily automated and each sample is subjected to a fresh separation column. This insures maximum precision and zero carryover from sample-to-sample. PhyNexus’ PhyTip column technology provides an optimized ChIP separation format that meets the specifications described above. As shown in the photo below at left, the PhyNexus PhyTip 1000+ (top) and 200+ (bottom) column products each possess a microcolumn of agarose-based resin at the opening of a pipet tip. As shown in the drawing below at right, the design of the PhyTip column is such that highly efficient capture of the target protein is achieved by maximizing transport to the agarose beads, which is enhanced through repeated back-and-forth sample exposure cycles. This design also insures exceptional purity for the target protein by reducing the amount of unwashed volume to virtually zero, thus minimizing any opportunities for non-specific binding events. Lastly, this same design provides for high-yield elutions to occur into exceptionally small volumes. All of these features work together to provide dramatically increased target protein concentrations at high levels of purity, all from starting samples as small as a few hundred microliters. PhyTip Column Technology PhyTip column technology is a simple and straightforward means of performing fully optimized ChIP separations prior to conventional ChIP, ChIP-chip or validation of individual ChIP-chip interactions – all of which can also be easily automated for high-throughput procedures. The benefits described above as being provided by the PhyTip column technology are illustrated below for different colon cancer cell lines and different histone modifications associated with the hMLH1 gene.
  • 3. Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP) Page 3 Procedures with PhyTip® Column Technology Materials and Methods Antibodies and cell lines Histone H3 antibodies, SDS Lysis Buffer, ChIP Dilution Buffer, and salmon-sperm DNA/Protein A and Protein G agarose were obtained from Upstate Biotechnology (Lake Placid, NY). RKO and SW480 cell lines were obtained from the American Type Culture Collection. Dulbecco’s modified growth medium, L-15 medium and fetal bovine serum were obtained from Invitrogen (Carlsbad, CA). Protein G PhyTip® Columns were from PhyNexus, Inc. (San Jose, CA). Cell growth, crosslinking and chromatin preparation RKO and SW480 colorectal cancer cell lines were obtained from American Type Culture Collection. RKO cells were grown in high-glucose Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. SW480 cells were grown in L-15 medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin in a humidified atmosphere containing 5% CO2 at 37°C. EZChIP Assay Kit from Upstate Biotechnology was used for chromatin preparation with some modifications. 1x106 cells were harvested from each cell line. Proteins were cross-linked to DNA by addition of formaldehyde directly to the culture medium to a final concentration of 1% for 10 min at room temperature. The cross-linking reaction was quenched by adding 0.125 M glycine for 5 min at room temperature. The medium was then removed and cells were washed with 1X PBS containing a combination of protease inhibitors. The PBS was removed and 0.2X trypsin was added to the cells. After a 5-min incubation at 37°C, ice-cold 1X PBS containing 10% FBS was added to stop trypsinization. The cells were pelleted, and washed twice with 1X PBS plus protease inhibitors as above and resuspended in 200 µl 1% SDS, 10mM EDTA, 50mM Tris, pH 8.1. The lysate from each cell line was diluted to a final volume of 2 mL in 0.01% SDS, 1.1% TritonX-100, 1.2mM EDTA, 16.7mM Tris-HCl, pH 8.1, 167mM NaCl. DNA was sheared by sonication on ice using a Sonifier 250 ultrasonic cell disruptor (Branson Ultrasonics), 40% duty cycle for 2 minutes at low power. Insoluble material was removed by centrifugation at 12,000 x g for 10 minutes at 4°. 20 µl of each sample was retained as DNA input control for PCR analysis. The sonicated samples were pre-cleared with 80 µl of salmon sperm DNA/Protein A and Protein G agarose beads (3:1 ratio of Protein A to Protein G) for 1 h at 4°C with agitation followed by centrifugation at 4000 x g for 1 minute to pellet agarose beads. The resulting supernatant from each cell line was divided equally into five 400 µl fractions. 2.5 µl of each antibody was added to separate fractions and incubated overnight at 4ºC. Control samples containing no antibody were also prepared for the two cell lines. Following the overnight incubation, each sample was divided into two 200 µl fractions for analysis using conventional immunoprecipitation and PhyTip column enrichment. Standard Chromatin Immunoprecipitation Ten microliters of the 3:1 Protein A and Protein G agarose were added to each sample for one hour at 4ºC with agitation followed by centrifugation at 4000 x g for 1 minute to pellet agarose beads. The beads were washed by resuspending in 1ml ice-cold Low-Salt Wash Buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, 150mM NaCl) followed by centrifugation at 4000 x g for 1 minute. The wash was repeated once with High Salt Wash Buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, 500mM NaCl), once with LiCl Wash Buffer (0.25M LiCl, 1% IGEPAL-CA630, 1% deoxycholic acid (sodium salt), 1mM EDTA, 10mM Tris, pH 8.1) and two washes with TE Wash Buffer (10mM Tris-HCl, 1mM EDTA, pH 8.0). Following the final wash step, the immune complex was extracted from the beads by adding 120 µl Elution Buffer (1% SDS. 0.1M NaHCO3) at room temperature for 15 minutes.
  • 4. Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP) Page 4 Procedures with PhyTip® Column Technology Chromatin Immunoprecipitation with PhyTip Columns Protein G PhyTip columns (5 µl bed volume) were blocked with 30 µg/mL salmon sperm DNA in PBS using a single intake/expel cycle of 190 µl at a flow rate of 50 µl/min. The samples, wash, and elution buffers were placed in individual wells of a microtiter plate (200 µl per well). Liquid handling steps were performed using the PhyNexus ME-200 computer- controlled multichannel flow controller. All of the actions associated with the ChIP protocol can be completely automated through an MEA Personal Purification System, as shown in Figure 1. Figure 1. PhyNexus MEA Personal Purification System Capture of the immune complex was achieved by passing the samples back and forth through the column using an intake/ expel volume of 190 µl for nine cycles at a flow rate of 150 µl/min. The columns were washed with the same series of buffers (Low Salt Wash, High Salt Wash, LiCl Wash, TE Wash) as described in the preceding section by passing 190 µl of each wash solution through the columns for three cycles at a flow rate of 200 µl/min. The elution step was performed by passing 120 µl of elution buffer back and forth through the column for five cycles at a flow rate of 50 µl/min. This process is illustrated in Figure 2. Figure 2. PhyTip ChIP extraction process
  • 5. Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP) Page 5 Procedures with PhyTip® Column Technology PCR Amplification After elution from the beads and columns, each sample was heated at 65ºC for four hours to reverse the DNA-chromatin crosslinking, followed by Proteinase K digestion, phenol:chloroform extraction and ethanol precipitation to recover the DNA. Alternatively the DNA can undergo high-yield quantitative purifications in an entirely automated and high-throughput manner by applying reverse-phase PhyTip columns. A 266 bp sequence of the 5’ upstream region of the hMLH1 gene (AB017806) was amplified via PCR. The sequence of the primers used were: Forward: 5’ GGCTCCACCAC TAAATAACGCTG, Reverse: 5’ GCCTCTGCTGAGGTGATCTGG. Amplification was performed using Taq DNA Polymerase (Roche) using the following program: 95ºC for 5 min (95ºC for 45 s, 60ºC for 45 s, 72ºC for 45 s for 35 cycles), 72ºC for 10 min, heated lid 105ºC. PCR products were visualized using agarose gel electrophoresis and EtBr staining of amplicons. Results Acetylation and methylation patterns of histone H3 surrounding the promoter region of the mismatch repair gene hMLH1 in colorectal cancer cell lines RKO (hMLH1 promoter silenced) and SW480 (hMLH1 promoter active) have been described previously3, and were used for the purpose of comparing results obtained by standard ChIP procedures to those obtained by PhyTip ChIP procedures. Acetylation of Histone H3 The first histone modification studied was acetylation of Histone H3, with the gel image shown below in Figure 3. The symbols above the individual lanes signify the absence (-) or presence (+) of antibody. Therefore, all lanes without antibody should show no PCR product – any PCR product that does show in these lanes would be the result of inadequate washing of non-specific DNA binding to the resin itself or any other potentially contaminating surfaces. In addition, for those cases where antibody is present for this particular histone modification, there should be a clear PCR product present in the case of SW480 cells and no PCR product in the case of RKO cells. Any PCR product that does show in the RKO cell line-plus-antibody lane would be a false positive. The PhyTip ChIP column procedure generates a strong PCR product for the SW480 cell line, with no discernible PCR product in any of the other lanes – indicating that the wash procedure was sufficient for both cell lines, and that there was not a false positive for the RKO cell line. The standard ChIP procedure generates a clearly discernible signal for the SW480 cell line, with no discernible signal in the “no antibody” lane for this same cell line. However, there are faint PCR products in both lanes of the RKO cell line, indicating that the wash procedure for this cell line was not sufficient and runs the risk of contributing to false positive signals, as shown in the “with antibody” lane for the RKO cell line. Figure 3. Anti-acetyl-Histone H3 ChIP results, standard vs PhyTip processing
  • 6. Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP) Page 6 Procedures with PhyTip® Column Technology Dimethylation of Histone H3-K9 The second histone modification studied was dimethylation of Histone H3-K9 with the gel image shown below in Figure 4. Just as with the previous histone modification, all lanes without antibody should show no PCR product. Any PCR product that does show in these lanes would be the result of inadequate washing of non-specific DNA binding to the resin itself or any other potentially contaminating surfaces. In addition, for those cases where antibody is present for this particular histone modification, there should be a clear PCR product present in the case of RKO cell lines and no PCR product in the case of SW480 cell lines. Any PCR product that does show in the SW480 cell line-plus-antibody lane would be a false positive. The PhyTip ChIP column procedure generates a clearly discernible PCR product for the RKO cell line, with no discernible PCR product in any of the other lanes, indicating that the wash procedure was sufficient for both cell lines, and that there was not a false positive for the SW480 cell line. The standard ChIP procedure generates a very faint PCR product for the RKO cell line (and is close to being undetectable, and hence a false negative), with no discernible signal in the “no antibody” lane for this same cell line. However, there is also a faint PCR product in the “no antibody” lane for the SW480 cell line (and contrary to what is already known about this histone modification, is actually more discernable than the “with antibody” lane for the RKO cell line). This indicates that the wash procedure for this cell line was not sufficient and runs the risk of contributing to false positives. Figure 4. Anti-H3-K9-Me2 ChIP results, standard vs PhyTip processing Discussion As demonstrated for a known gene (hMLH1) oppositely regulated by two different H3 modifications in two different cell lines, PhyTip column technology can provide significant improvements in signal-to-noise for ChIP analyses. This translates to improvements in false positive error rates by providing more specific signals, as well as improvements in false negative error rates by providing stronger signals. These improvements in performance have implications in a variety of ChIP-related contexts. For one, conventional ChIP analyses whereby a set or sets of loci-specific primers will benefit from having an overall higher degree of reliability and automation. This would be specifically beneficial if a large number of experiments are performed for a particular event, or for validation of individual genome-wide interactions reported – as suggested by previous authors. In addition, the improvements can potentially lead to overall improvements in false negatives and false positives in ChIP-chip experiments. continued...
  • 7. Performance Enhancement and Automation of Chromatin Immunoprecipitation (ChIP) Page 7 Procedures with PhyTip® Column Technology Another advantage of the PhyTip column approach to ChIP analyses is that the improvements described above are obtained with significantly reduced starting sample quantities. In many standard ChIP procedures, the starting number of cells is typically 1x106, which are then lysed and commonly brought to a volume of 2 mL for standard ChIP processing. In the case of PhyTip processing for ChIP analyses, 0.2 mL of lysate volume representing the equivalent of 1x105 cells provided the improvements reported over processing this same volume by standard ChIP procedures. The improved results for smaller amounts of starting material mean that PhyTip ChIP approaches are well-suited to those situations where the starting cells are very precious and limited in quantity, such as primary tumor cell lines. In addition, this advantage also means that larger numbers of different experiments can be performed upon the same sample, e.g. examining a range of different histone modifications within a given sample. In addition to these substantial benefits for ChIP analyses, the PhyTip column approach to ChIP analyses lends itself to very simple automation of the separation process. This creates not only greater precision in ChIP analyses, but also dramatically reduces hands-on time. In addition, the PhyNexus MEA Personal Purification System has accessory items such as on-board heating that can automate the process of reversing protein-DNA crosslinking with 65°C incubations, and the ability to also perform standard pipetting operations on the MEA allows for addition of Proteinase K to these de-crosslinked samples. Furthermore, reverse-phase DNA purification can be performed in a high-yield and automated manner on the MEA Personal Purification System, thus eliminating the need for phenol-chloroform extractions requiring labor-intensive manipulation of the samples resulting in losses of DNA. Acknowledgments Drs. Jeffrey Sklar and Hui Li of Yale Medical School are gratefully acknowledged for providing the experimental work and data for this Technical Note. References 1. B.D. Strahl and C.D. Allis, “The language of covalent histone modifications”, Nature, 2000, 403, 41-45. 2. T. Jenuwein and C.D. Allis, “Translating the histone code”, Science, 2001, 293, 1074-1080. 3. J.A. Fahrner, S. Eguchi, J.G. Herman and S.B. Baylin, “Dependence of histone modifications and gene expression on DNA hypermethylation in cancer”, Cancer Res., 2002, 62, 7213-7218. 4. S. Chuikov, J.K. Kurash, J.R. Wilson, B. Xiao, N. Justin, G.S. Ivanov, K. McKinney, P. Tempst, C. Prives, S.J. Gamblin, N.A. Barlev and D. Reinberg, “Regulation of p53 activity through lysine methylation”, Nature, 2004, 432, 353-360. 5. J.C. Wang, M.K. Derynck, D.F. Nonaka, D.B. Khodabakhsh, C. Haqq and K.R. Yamamoto, “Chromatin immunopreciptation (ChIP) scanning identifies primary glucocorticoid receptor target genes”, Proc. Natl. Acad. Sci. USA, 2004, 101, 15603-15608. 6. J.V. Geisberg and K. Struhl, “Quantitative sequential chromatin immunoprecipitation, a method for analyzing cooccupancy of proteins at genomic regions in vivo”, Nucleic Acids Res., 2004, 32, e151. 7. T.H. Kim, L.O. Barrera, M. Zheng, C. Qu, M.A. Singer, T.A. Richmond, Y. Wu, R.D. Green and B. Ren, “A high-resolution map of active promoters in the human genome”, Nature, 2005, 436, 876-880. 8. B.E. Bernstein, E.L. Humphrey, R.L. Erlich, R. Schneider, P. Bouman, J.S. Liu, T. Kouzarides and S.L. Schreiber, “Methylation of histone H3 Lys 4 in coding regions of active genes”, Proc. Natl. Acad. Sci USA, 2002, 99, 8695-8700. 9. M.J. Oberley, D.R. Inman and P.J. Farnham, “E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9”, J. Biol. Chem., 2003, 278, 42466-42476. 10. T.I. Lee, et al, “Transcriptional regulatory networks in Saccharomyces cerevisiae”, Science, 2002, 298, 799-804. 11. Z. Li, S. Van Calcar, C. Qu, W.K. Cavenee, M.Q. Zhang and B. Ren, “A global transcriptional regulatory role for c-Myc in Burkitt’s lymphoma cells”, Proc. Natl. Acad. Sci. USA, 2003, 100, 8164-8169. 12. E.M. Conlon, X.S. Liu, J.D. Lieb and J.S. Liu, “Integrating regulatory motif discovery and genome-wide expression analysis”, Proc. Natl. Acad. Sci. USA, 2003, 100, 3339-3344. 13. P. Hong, X.S. Liu, Q. Zhou, X. Lu, J.S. Liu and W.H. Wong, “A boosting approach for motif modeling using ChIP-chip data”, Bioinformatics, 2005, 21, 2636-2643. Copyright © 2005, PhyNexus, Inc., All Rights Reserved PSL # 90-10-03 September 2005 www.phynexus.com